These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 28289144

  • 1. Staphylococcus aureus Survives in Cystic Fibrosis Macrophages, Forming a Reservoir for Chronic Pneumonia.
    Li C, Wu Y, Riehle A, Ma J, Kamler M, Gulbins E, Grassmé H.
    Infect Immun; 2017 May; 85(5):. PubMed ID: 28289144
    [Abstract] [Full Text] [Related]

  • 2. Extended Staphylococcus aureus persistence in cystic fibrosis is associated with bacterial adaptation.
    Hirschhausen N, Block D, Bianconi I, Bragonzi A, Birtel J, Lee JC, Dübbers A, Küster P, Kahl J, Peters G, Kahl BC.
    Int J Med Microbiol; 2013 Dec; 303(8):685-92. PubMed ID: 24183484
    [Abstract] [Full Text] [Related]

  • 3. Lung pathology in response to repeated exposure to Staphylococcus aureus in congenic residual function cystic fibrosis mice does not increase in response to decreased CFTR levels or increased bacterial load.
    Davidson DJ, Webb S, Teague P, Govan JR, Dorin JR.
    Pathobiology; 2004 Dec; 71(3):152-8. PubMed ID: 15051928
    [Abstract] [Full Text] [Related]

  • 4. Lack of Sphingosine Causes Susceptibility to Pulmonary Staphylococcus Aureus Infections in Cystic Fibrosis.
    Tavakoli Tabazavareh S, Seitz A, Jernigan P, Sehl C, Keitsch S, Lang S, Kahl BC, Edwards M, Grassmé H, Gulbins E, Becker KA.
    Cell Physiol Biochem; 2016 Dec; 38(6):2094-102. PubMed ID: 27184795
    [Abstract] [Full Text] [Related]

  • 5. Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosis.
    Wolter DJ, Emerson JC, McNamara S, Buccat AM, Qin X, Cochrane E, Houston LS, Rogers GB, Marsh P, Prehar K, Pope CE, Blackledge M, Déziel E, Bruce KD, Ramsey BW, Gibson RL, Burns JL, Hoffman LR.
    Clin Infect Dis; 2013 Aug; 57(3):384-91. PubMed ID: 23625938
    [Abstract] [Full Text] [Related]

  • 6. Adaptation of Pseudomonas aeruginosa in Cystic Fibrosis airways influences virulence of Staphylococcus aureus in vitro and murine models of co-infection.
    Baldan R, Cigana C, Testa F, Bianconi I, De Simone M, Pellin D, Di Serio C, Bragonzi A, Cirillo DM.
    PLoS One; 2014 Aug; 9(3):e89614. PubMed ID: 24603807
    [Abstract] [Full Text] [Related]

  • 7. Toll-like receptor 2 has a prominent but nonessential role in innate immunity to Staphylococcus aureus pneumonia.
    Skerrett SJ, Braff MH, Liggitt HD, Rubens CE.
    Physiol Rep; 2017 Nov; 5(21):. PubMed ID: 29142002
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection.
    Coleman FT, Mueschenborn S, Meluleni G, Ray C, Carey VJ, Vargas SO, Cannon CL, Ausubel FM, Pier GB.
    Proc Natl Acad Sci U S A; 2003 Feb 18; 100(4):1949-54. PubMed ID: 12578988
    [Abstract] [Full Text] [Related]

  • 11. Impact of Staphylococcus aureus on the pathogenesis of chronic cystic fibrosis lung disease.
    Kahl BC.
    Int J Med Microbiol; 2010 Dec 18; 300(8):514-9. PubMed ID: 20843739
    [Abstract] [Full Text] [Related]

  • 12. Murine models of acute and chronic lung infection with cystic fibrosis pathogens.
    Bragonzi A.
    Int J Med Microbiol; 2010 Dec 18; 300(8):584-93. PubMed ID: 20951086
    [Abstract] [Full Text] [Related]

  • 13. Coculture of Staphylococcus aureus with Pseudomonas aeruginosa Drives S. aureus towards Fermentative Metabolism and Reduced Viability in a Cystic Fibrosis Model.
    Filkins LM, Graber JA, Olson DG, Dolben EL, Lynd LR, Bhuju S, O'Toole GA.
    J Bacteriol; 2015 Jul 18; 197(14):2252-64. PubMed ID: 25917910
    [Abstract] [Full Text] [Related]

  • 14. Pulmonary infection of cystic fibrosis mice with Staphylococcus aureus requires expression of α-toxin.
    Keitsch S, Riethmüller J, Soddemann M, Sehl C, Wilker B, Edwards MJ, Caldwell CC, Fraunholz M, Gulbins E, Becker KA.
    Biol Chem; 2018 Sep 25; 399(10):1203-1213. PubMed ID: 29613852
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interleukin-17 Pathophysiology and Therapeutic Intervention in Cystic Fibrosis Lung Infection and Inflammation.
    Hsu D, Taylor P, Fletcher D, van Heeckeren R, Eastman J, van Heeckeren A, Davis P, Chmiel JF, Pearlman E, Bonfield TL.
    Infect Immun; 2016 Sep 25; 84(9):2410-21. PubMed ID: 27271746
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Staphylococcus aureus in early cystic fibrosis lung disease.
    Wong JK, Ranganathan SC, Hart E, Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF).
    Pediatr Pulmonol; 2013 Dec 25; 48(12):1151-9. PubMed ID: 23970476
    [Abstract] [Full Text] [Related]

  • 20. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC, de Lima Marson FA, Ribeiro JD, Paschoal IA, Pereira MC, Ribeiro AF, Bertuzzo CS.
    Gene; 2014 May 01; 540(2):183-90. PubMed ID: 24583165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.